The pregnant women living with hiv antiretroviral therapy coverage for pmtct in Haiti currently stands at 62%, marking a decrease of 6% (-8.8%) compared to 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Haiti
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Haiti
PMTCT antiretroviral therapy coverage
More indicators for Haiti
Male unintentional poisoning
1.9
-0.1
(2019)
Female wasting in children
3.3%
-1.4%
(2017)
Female prevalence of HIV
0.9%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar48
+intl dollar1
(2021)
Birth registration
84.8%
+5.1%
(2017)
Contraceptive modern method prevalence
31.8%
+0.5%
(2017)
Haiti PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 62% | -6% |
| 2021 | 68% | -4% |
| 2020 | 72% | -16% |
| 2019 | 88% | -3% |
| 2018 | 91% | +5% |
| 2017 | 86% | +5% |
| 2016 | 81% | -6% |
| 2015 | 87% | -4% |
| 2014 | 91% | -9% |
| 2013 | 100% | 0% |
| 2012 | 100% | +23% |
| 2011 | 77% | +30% |
| 2010 | 47% | -11% |
| 2009 | 58% | +9% |
| 2008 | 49% | +2% |
| 2007 | 47% | +23% |
| 2006 | 24% | +14% |
| 2005 | 10% | +9% |
| 2004 | 1% | +1% |
| 2003 | 0% | 0% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |